ScreenPoint Medical locks in $28m Series C
Netherlands-based ScreenPoint Medical, an AI technology company focused on early detection of breast cancer, has raised $28 million in Series C funding.
Netherlands-based ScreenPoint Medical, an AI technology company focused on early detection of breast cancer, has raised $28 million in Series C funding.
Copyright PEI Media
Not for publication, email or dissemination
